Marc F. Pelletier, Phd Email & Phone Number
@aeromics.com
4 phones found area 216 and 203
LinkedIn matched
Who is Marc F. Pelletier, Phd? Overview
A concise factual answer block for searchers comparing this professional profile.
Marc F. Pelletier, Phd is listed as Chief Executive Officer, Director at REMED Therapeutics, a company with 2 employees, based in Cleveland, Ohio, United States. AeroLeads shows a work email signal at aeromics.com, phone signal with area code 216, 203, and a matched LinkedIn profile for Marc F. Pelletier, Phd.
Marc F. Pelletier, Phd previously worked as Chief Executive Officer, Director at Personal Therapeutics and Entrepreneur-in-Residence at Yale University School Of Medicine. Marc F. Pelletier, Phd holds Post-Doctoral Fellow, Department Of Cellular & Molecular Physiology from Yale University School Of Medicine.
Email format at REMED Therapeutics
This section adds company-level context without repeating Marc F. Pelletier, Phd's masked contact details.
AeroLeads found 1 current-domain work email signal for Marc F. Pelletier, Phd. Compare company email patterns before reaching out.
About Marc F. Pelletier, Phd
Marc F. Pelletier, Phd is a Chief Executive Officer, Director at REMED Therapeutics. He possess expertise in drug discovery, biotechnology, biochemistry, lifesciences, molecular biology and 32 more skills.
Listed skills include Drug Discovery, Biotechnology, Biochemistry, Lifesciences, and 33 others.
Marc F. Pelletier, Phd's current company
Company context helps verify the profile and gives searchers a useful next step.
Marc F. Pelletier, Phd work experience
A career timeline built from the work history available for this profile.
Chief Executive Officer, Director
CurrentPersonal Therapeutics LLC, a spin-out of the Yale School of Medicine, is advancing its lead BP-1002, a Renalase (RNLS) agonist, to IND for Acute Pancreatitis (AP). Additional indications include acute kidney injury (AKI) and viral-induced hyperinflammation. BP-1002 has a first- and best-in-class attributes as a therapeutic for acute inflammatory AP and.
Entrepreneur-In-Residence
Current
Strategic Advisor, Director (Former), Co-Founder
CurrentIridia is developing the world’s first commercially-attractive, DNA-based data storage solution. By combining DNA polymer synthesis technology, electronic nano-switches and semiconductor fabrication technologies, Iridia is developing a highly-parallel format to enable an array of nanomodules with the potential to store data at exceptionally high density.
Chairman & Chief Executive Officer
Gardiner Healthcare Acquisitions Corp. (NASDAQ:GDNRU,GDNR,GDNRW) is a special purpose acquisition company (SPAC) formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. While we may pursue an acquisition.
Chief Executive Officer, Co-Founder
Dr. Pelletier founded Aeromics at Yale School of Medicine and was CEO from 2008-2019. Building the company from the ground up, Dr. Pelletier oversaw strategic and scientific operations. He led Aeromics’ drug discovery program which produced inhibitors of Aquaporins for the treatment of cerebral edema (or brain swelling). Aeromics' AER-271 is the first.
Marc F. Pelletier, Phd education
Post-Doctoral Fellow, Department Of Cellular & Molecular Physiology
Post-Doctoral Fellow, James Hudson Brown - Alexander Brown Coxe, Department Of Molecular Biophysics & Biochemistry
Post-Doctoral Fellow, James Hudson Brown - Alexander Brown Coxe, Department Of Genetics
Phd, Biology
Msc, Biology (Plant Molecular Biology/Genetics)
Graduate Studies - Qualifying, Physiology
Graduate Studies - Qualifying, Biology
Bsc, Biology/Economics
Diplôme D'Études Collégiales (Dec), Sciences Pures Et Appliquées
Frequently asked questions about Marc F. Pelletier, Phd
Quick answers generated from the profile data available on this page.
What company does Marc F. Pelletier, Phd work for?
Marc F. Pelletier, Phd works for REMED Therapeutics.
What is Marc F. Pelletier, Phd's role at REMED Therapeutics?
Marc F. Pelletier, Phd is listed as Chief Executive Officer, Director at REMED Therapeutics.
What is Marc F. Pelletier, Phd's email address?
AeroLeads has found 1 work email signal at @aeromics.com for Marc F. Pelletier, Phd at REMED Therapeutics.
What is Marc F. Pelletier, Phd's phone number?
AeroLeads has found 4 phone signal(s) with area code 216, 203 for Marc F. Pelletier, Phd at REMED Therapeutics.
Where is Marc F. Pelletier, Phd based?
Marc F. Pelletier, Phd is based in Cleveland, Ohio, United States while working with REMED Therapeutics.
What companies has Marc F. Pelletier, Phd worked for?
Marc F. Pelletier, Phd has worked for Remed Therapeutics, Personal Therapeutics, Yale University School Of Medicine, Iridia, Inc., and Gardiner Healthcare Acquisitions Corp..
How can I contact Marc F. Pelletier, Phd?
You can use AeroLeads to view verified contact signals for Marc F. Pelletier, Phd at REMED Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Marc F. Pelletier, Phd attend?
Marc F. Pelletier, Phd holds Post-Doctoral Fellow, Department Of Cellular & Molecular Physiology from Yale University School Of Medicine.
What skills is Marc F. Pelletier, Phd known for?
Marc F. Pelletier, Phd is listed with skills including Drug Discovery, Biotechnology, Biochemistry, Lifesciences, Molecular Biology, Cell Culture, Life Sciences, and Genetics.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial